DiseaseID 5116

卡波西肉瘤

disease

NCI2016_NCI-GLOSS_1602D:A type of cancer characterized by the abnormal growth of blood vessels that develop into skin lesions or occur internally.|NCI2016_02D:A malignant neoplasm characterized by a vascular proliferatio

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Disease: 1Symptom: 8Target: 24Links: 32
Arranging relationship network...

Record Fields

Scalar fields from the final disease record.

Disease Id
5116
Core Entity Id
61565
Source Entity Count
1
Preferred Name
Kaposi Sarcoma
Name Cn
卡波西肉瘤
Name Pinyin
Ka Bo Xi Rou Liu
Name En
Kaposi Sarcoma
Name Latin
Bilingual Status
complete
Disease Type
disease
Umls Disease Type
Neoplastic Process
Disgenet Type
disease
Mesh Class
Infections; Neoplasms
Do Class
disease of anatomical entity; disease of cellular proliferation
Hpo Class
Neoplasm; Abnormality of the integument
Mesh Class Name
Neoplasms; Infections
Hpo Class Name
Abnormality of the integument; Neoplasm
Do Class Name
disease of anatomical entity; disease of cellular proliferation
Disease Definition
NCI2016_NCI-GLOSS_1602D:A type of cancer characterized by the abnormal growth of blood vessels that develop into skin lesions or occur internally.|NCI2016_02D:A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).|MSH2017_2016_08_12:A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.|MEDLINEPLUS_20151021:<p>Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and throat or in other organs. The patches are usually red or purple and are made of cancer cells and blood cells. The red and purple patches often cause no symptoms, though they may be painful. If the cancer spreads to the digestive tract or lungs, bleeding can result. Lung tumors can make breathing hard.</p> <p>Before the <a href='https://www.nlm.nih.gov/medlineplus/hivaids.html'>HIV/AIDS</a> epidemic, KS usually developed slowly. In HIV/AIDS patients, though, the disease moves quickly. Treatment depends on where the lesions are and how bad they are. Treatment for HIV itself can shrink the lesions. However, treating KS does not improve survival from HIV/AIDS itself.</p> <p >NIH: National Cancer Institute</p>|HPO2016_07_04:A systemic disease which can present with cutaneous lesions with or without internal involvement. Tumors are caused by Human herpesvirus 8 (HHV8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV). [HPO:sdoelken]|CSP2006:multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas; occurs spontaneously in Jewish and Italian males; aggressive variant in young children is endemic in some areas of Africa; a third form occurs in about 0.04% of kidney transplant patients; there is also a high incidence in AIDS patients; human herpesvirus 8 is the suspected cause.|CHV2011_02:a cancer that causes patches of abnormal tissue to grow under the skin,
Version
v2
Suppressed
No

Names

Preferred names, aliases, and source labels retained in the final schema.

Name
Kaposi Sarcoma
Role
preferred
Name
Kaposi'S Sarcoma of Palate
Role
preferred
Name
Kaposi'S Sarcoma of Skin
Role
preferred
Name
Kaposi'S Sarcoma
Role
alias
Name
Kaposi'S Sarcoma, Unspecified
Role
alias
Name
Sarcoma, Kaposi
Role
alias

Cross References

Trusted external identifiers retained for this final record.

Hpo
HP:0100726
Herb
HBDIS002675HBDIS003804HBDIS003805
Me Sh
D012514
Umls
C0036220
Icd10
C46C46.0C46.2C46.9
Sym Map
SMDE10155
Do Class
DOID:14566DOID:7
Dis Ge Net
C0036220C0153560C0153562
Umls Sty
T191
Hpo Class
HP:0001574HP:0002664
Me Sh Class
C01C04
Etcm Disease
Kaposi Sarcoma
Tcmbank Disease
139742301931196
Itcmdb Generated
ITX-DISEASE-E423C8FB2B3A

Attributes

Merged source attributes and domain-specific metadata.

Version
v2
Suppress
0
Page Title
Disease Kaposi Sarcoma Details page
Do Class Name
disease of anatomical entity; disease of cellular proliferation
Disease Type
disease
Hpo Class Name
Abnormality of the integument; Neoplasm
Do Disease Class
disease of anatomical entity; disease of cellular proliferation
Hpo Disease Class
Neoplasm; Abnormality of the integument
Umls Disease Type
Neoplastic Process
Basic Information
Disease Name
Kaposi Sarcoma
Global Category
Cancer diseases;Fetal diseases;Genetic diseases;Rare diseases
Anatomical Category
Blood diseases;Cardiovascular diseases
Disease Definition
NCI2016_NCI-GLOSS_1602D:A type of cancer characterized by the abnormal growth of blood vessels that develop into skin lesions or occur internally.|NCI2016_02D:A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).|MSH2017_2016_08_12:A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.|MEDLINEPLUS_20151021:<p>Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and throat or in other organs. The patches are usually red or purple and are made of cancer cells and blood cells. The red and purple patches often cause no symptoms, though they may be painful. If the cancer spreads to the digestive tract or lungs, bleeding can result. Lung tumors can make breathing hard.</p> <p>Before the <a href='https://www.nlm.nih.gov/medlineplus/hivaids.html'>HIV/AIDS</a> epidemic, KS usually developed slowly. In HIV/AIDS patients, though, the disease moves quickly. Treatment depends on where the lesions are and how bad they are. Treatment for HIV itself can shrink the lesions. However, treating KS does not improve survival from HIV/AIDS itself.</p> <p >NIH: National Cancer Institute</p>|HPO2016_07_04:A systemic disease which can present with cutaneous lesions with or without internal involvement. Tumors are caused by Human herpesvirus 8 (HHV8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV). [HPO:sdoelken]|CSP2006:multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas; occurs spontaneously in Jewish and Italian males; aggressive variant in young children is endemic in some areas of Africa; a third form occurs in about 0.04% of kidney transplant patients; there is also a high incidence in AIDS patients; human herpesvirus 8 is the suspected cause.|CHV2011_02:a cancer that causes patches of abnormal tissue to grow under the skin,
Me Sh Disease Class
Infections; Neoplasms
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Neoplasms; Infections
Umls Semantic Type Name
Neoplastic Process